Company demonstrates that CTLM detects tumor angiogenesis.

2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Imaging Diagnostic Systems, Inc., (IMDS) has confirmed that their Computed Tomographic Laser Breast Imaging System (CTLM) can depict angiogenesis associated with tumors.

Dr. Eric Milne, professor emeritus of radiology and medicine, UC at Irvine, California, chief radiologist for Imaging Diagnostic Systems, Inc., stated, "It is of crucial importance for us to be able to prove to radiologists that, when they image the breast using CTLM, the abnormal vessels they see within the breast in the location of a cancer truly reflect the growth of new tumor vessels (angiogenesis). Our ability to use the new technique of 'fusion' images has now provided us with the proof we sought.

"By fusing (superimposing) CTLM and MRI images of the same breast we have demonstrated accurate geographic correlation between the vessels shown by CTLM and those shown by MRI, the present 'gold standard' for visualizing blood vessels in the breast," Milne said.

"This is an exciting and important step forward in validating that, using hemoglobin alone as an endogenous contrast agent, CTLM provides valid information which will be of assistance in differentiating benign from malignant lesions on the mammogram, with the potential of markedly reducing the present very large numbers of negative biopsies," Milne added. "Currently, approximately 80 out of every 100 biopsies performed come back negative for cancer."

The company also ...